Tissue and Organ Transplantation Market Overview:

The global tissue and organ transplantation market are projected to reach a valuation of USD 39,528.63 Mn by 2031 at a CAGR of 9.10%, from USD 16,544.91 Mn in 2021.

Transplantation is the process of replacing a damaged or unhealthy tissue or organ with one that has been sourced from another body. The field of tissue and organ transplantation is extremely important in modern medicine. For example, bone marrow transplantation may be used to treat leukemia, and has aided medical professionals in healing patients who suffer from debilitating diseases that would have otherwise killed them. Tissue and organ transplantation is an emerging field in medicine, but there are still many barriers to the development of transplantation techniques.

Request Covid - 19 Impact

Due to advances in medicine, there have been many breakthroughs in organ transplantation. The most common organs transplanted are kidneys, liver, and lungs. Transplant recipients often receive an organ transplant from a living donor. There are also people who have their organs or tissue donated when they die in order for someone else to receive a transplant. This increases the availability of organs and tissue available for a transplant which allows a greater number of individuals to receive transplants.

Transplantation of tissue and organs is the process by which a surgical procedure is carried out to replace diseased or injured parts of a body with healthy tissue or organs from a donor. This process has been done for more than 50 years and its success rates have skyrocketed since the introduction of new technologies, such as xenotransplantation, which allows for the transplantation of animal tissue and organs in humans to replace diseased or injured tissues and organs.

Global Tissue and Organ Transplantation Market Revenue (US$ Mn), 2021–2031:

The demand for transplantation procedures is growing at an exponential rate. The main factors propelling the revenue growth of this market are the overall increase in life expectancy, an upsurge in the prevalence of chronic diseases, as well as an increase in medical tourism. As more individuals become eligible for organ transplants, the need for qualified organ donors also subsequently increases. One reason behind this trend is that more people are living longer lives due to advances in healthcare. Many individuals are at a greater risk of organ failure as they age past their younger years. In order to deal with this, doctors will often suggest an organ transplant depending on the severity of that patient’s illness. A donor's organs are removed from the body and have been carefully examined by a doctor before being transplanted into another person who is in need of them. When this procedure is successful, it can be a great way to save lives.

Researchers and physicians have made significant advances in transplanting tissue and organs from one individual to another. However, the process is not without risks and it poses a number of ethical challenges. A major concern with tissue and organ transplants is the risk of a patient's immune system rejecting said transplanted organs or tissue. The body recognizes that the new tissue or organ does not belong in its system and will then proceed to mount an attack against it. Furthermore, the global tissue and organ transplantation industry are likely to be hampered by a scarcity of organs for the treatment of organ failure. The demand for organs is far greater than the supply. According to the United States Department of Health and Human Services, there were 43,201 patients in need of kidney transplants in the United States in 2019, but only 23,401 kidney transplant procedures were carried out. These are certain factors that may hamper the economic trajectory of this market over the forecast period.

An increase in the number of individuals waiting for organ and tissue transplants, as well as an increase in death rates due to insufficient organ and tissue transplantation, may present opportunities for the tissue and organ transplantation market.

In May 2019, researchers from AMALNA Consulting and RMIT University, in partnership with Tithon Biotech Inc., anticipated the typical frequencies of parathyroid hormone activities, including differentiation of stem cells into osteoblasts. The findings of this study could contribute to the development of better stem cell differentiation strategies for tissue transplantation and repair.

This research report on the global tissue and organ transplantation market includes major company profiles such as:

• CryoLife Inc.
• Folio Biosciences
• Arthrex
• Abbvie Inc.
• Zimmer Biomet
• Medtronic PLC
• Novartis AG
• Stryker Corporation
• BiolifeSolutions Inc.
• Teva Pharmaceuticals
• Veloxis Pharmaceutical
• Others.

Global Tissue and Organ Transplantation Market Segmentation is Based on Product Types, Application, End-Users, and Region

Based on Product Types

• Tissue Products
• Preservation Solutions
• Immunosuppressive Drugs

Based on Application

• Organ Transplantation
  • Heart
  • Kidneys
  • Liver
  • Lungs
  • Pancreas
• Tissue Transplantation
  • Cornea
  • Heart Valve
  • Skin Grafts
  • Vascular Grafts
  • Bone Marrow
  • Bone Grafts

Based on End-Users

• Hospitals
• Transplant Centers
• Other End-Users

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

For the Tissue and Organ Transplantation Market research study, the following years have been considered to estimate the market size: